N Anthony Coles

N Anthony Coles has an estimated net worth of $108 Million. This is based on reported shares across multiple companies, which include LABORATORY CORP OF AMERICA HOLDINGS, REGENERON PHARMACEUTICALS, INC., MCKESSON CORP, Cerevel Therapeutics Holdings, Inc., CRISPR Therapeutics AG, Campus Crest Communities, Inc., YUMANITY THERAPEUTICS, INC., VERTEX PHARMACEUTICALS INC / MA, NPS PHARMACEUTICALS INC, and ONYX PHARMACEUTICALS INC.

2023 was N Anthony Coles's most active year for acquiring shares with 18 total transactions. N Anthony Coles's most active month to acquire stocks was the month of December. 2023 was N Anthony Coles's most active year for disposing of shares, totalling 32 transactions. N Anthony Coles's most active month to dispose stocks was the month of August. 2012 saw N Anthony Coles paying a total of $11,145,795.22 for 614,766 shares, this is the most they've acquired in one year. In 2012 N Anthony Coles cashed out on 800,771 shares for a total of $21,372,557.78, their largest year based on trade value.